CDKN2B-AS1 and neoplasm: ANRIL is involved in the expression regulation of three tumor suppressor genes at the CDKN2A/B locus (p16-CDKN2A, p15-CDKN2B, and p14-ARF), via a cis-acting, polycomb-mediated epigenetic mechanism.